These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16206166)

  • 1. Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
    Chen SH; Gillespie GY; Benveniste EN
    Glia; 2006 Jan; 53(2):191-200. PubMed ID: 16206166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
    Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
    Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.
    Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN
    J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of oncostatin M on trophoblast cells: influence on matrix metalloproteinases-2 and -9, and invasion activity.
    Ko HS; Kang HK; Kim HS; Choi SK; Park IY; Shin JC
    Placenta; 2012 Nov; 33(11):908-13. PubMed ID: 22931588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
    Weiss TW; Kvakan H; Kaun C; Zorn G; Speidl WS; Pfaffenberger S; Maurer G; Huber K; Wojta J
    J Mol Cell Cardiol; 2005 Sep; 39(3):545-51. PubMed ID: 15890357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
    J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
    Repovic P; Fears CY; Gladson CL; Benveniste EN
    Oncogene; 2003 Nov; 22(50):8117-24. PubMed ID: 14603252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin M signaling in human glioma cell lines.
    Krona A; Järnum S; Salford LG; Widegren B; Aman P
    Oncol Rep; 2005 May; 13(5):807-11. PubMed ID: 15809742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
    Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D
    Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
    Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
    Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
    J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells.
    Jorcyk CL; Holzer RG; Ryan RE
    Cytokine; 2006 Mar; 33(6):323-36. PubMed ID: 16713283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
    Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
    J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
    Loo WT; Chen JP; Chow LW; Chou JW
    Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
    Chen MH; Cui SX; Cheng YN; Sun LR; Li QB; Xu WF; Ward SG; Tang W; Qu XJ
    Anticancer Drugs; 2008 Nov; 19(10):957-65. PubMed ID: 18827560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro invasion/migration of human astroglioma cells.
    Jung JS; Ahn JH; Le TK; Kim DH; Kim HS
    Neurochem Int; 2013 Aug; 63(2):80-6. PubMed ID: 23684955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells.
    Kim SY; Jung SH; Kim HS
    Biochem Biophys Res Commun; 2005 Nov; 337(2):510-6. PubMed ID: 16198311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
    Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Kim WB; Kim SH; Lee SK
    Biochem Pharmacol; 2005 Dec; 71(1-2):21-31. PubMed ID: 16271263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N; Heath JK
    Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.